Oscar Health, Inc. (NYSE:OSCR) Receives Average Recommendation of “Hold” from Brokerages

Oscar Health, Inc. (NYSE:OSCR) has been assigned a consensus rating of “Hold” from the nine ratings firms that are covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating, four have issued a buy rating and one has issued a strong buy rating on the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $21.56.

OSCR has been the subject of several research reports. Piper Sandler reiterated an “overweight” rating and issued a $28.00 target price on shares of Oscar Health in a report on Tuesday, September 10th. Bank of America lowered shares of Oscar Health from a “neutral” rating to an “underperform” rating and lowered their price objective for the stock from $21.00 to $13.50 in a research note on Wednesday, November 6th. Jefferies Financial Group began coverage on shares of Oscar Health in a report on Tuesday, December 10th. They issued an “underperform” rating and a $12.00 price target for the company. Finally, UBS Group assumed coverage on shares of Oscar Health in a research report on Monday, October 7th. They issued a “neutral” rating and a $23.00 price target for the company.

Insider Buying and Selling at Oscar Health

In other Oscar Health news, Vice Chairman Joshua Kushner purchased 276,040 shares of the firm’s stock in a transaction on Monday, November 11th. The stock was bought at an average cost of $13.58 per share, for a total transaction of $3,748,623.20. Following the completion of the purchase, the insider now owns 5,031,262 shares in the company, valued at $68,324,537.96. This represents a 5.80 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CAO Victoria Baltrus sold 8,078 shares of the business’s stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $18.08, for a total value of $146,050.24. Following the sale, the chief accounting officer now owns 146,036 shares in the company, valued at $2,640,330.88. The trade was a 5.24 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders bought 1,055,478 shares of company stock worth $14,432,852 and sold 103,610 shares worth $1,847,519. 25.11% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Point72 Hong Kong Ltd acquired a new position in shares of Oscar Health in the 2nd quarter valued at $78,000. Quest Partners LLC acquired a new position in shares of Oscar Health in the second quarter valued at about $93,000. KBC Group NV raised its stake in shares of Oscar Health by 41.2% in the third quarter. KBC Group NV now owns 4,552 shares of the company’s stock worth $97,000 after purchasing an additional 1,328 shares during the last quarter. Amalgamated Bank lifted its holdings in shares of Oscar Health by 27.7% during the second quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock worth $106,000 after purchasing an additional 1,458 shares during the period. Finally, Optimum Investment Advisors purchased a new stake in Oscar Health in the third quarter valued at approximately $142,000. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Oscar Health Trading Up 4.4 %

OSCR stock opened at $14.09 on Wednesday. The company has a market capitalization of $3.48 billion, a PE ratio of -234.79 and a beta of 1.63. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. Oscar Health has a 12 month low of $8.14 and a 12 month high of $23.79. The firm’s 50-day moving average is $15.89 and its 200 day moving average is $17.41.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share for the quarter, missing the consensus estimate of ($0.20) by ($0.02). The company had revenue of $2.42 billion for the quarter, compared to the consensus estimate of $2.33 billion. Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The business’s revenue was up 68.3% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.29) EPS. On average, research analysts anticipate that Oscar Health will post -0.01 EPS for the current year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.